Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management
Even though an approved vaccine for hepatitis B virus (HBV) is available and widely used, over 257 million individuals worldwide are living with chronic hepatitis B (CHB) who require monitoring of treatment response, viral activity, and disease progression to reduce their risk of HBV-related liver d...
Main Authors: | Alicia Vachon, Carla Osiowy |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/6/951 |
Similar Items
-
Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection
by: Yayun Liu, et al.
Published: (2019-04-01) -
New perspectives of biomarkers for the management of chronic hepatitis B
by: Chih-Lin Lin, et al.
Published: (2016-12-01) -
Seroprevalence of hepatitis B and hepatitis C markers among children and adolescents in the south brazilian region: metropolitan area of Florianópolis, Santa Catarina
by: Andréia Royer Voigt, et al. -
New Markers in Monitoring the Reactivation of Hepatitis B Virus Infection in Immunocompromised Hosts
by: Valentina Svicher, et al.
Published: (2019-08-01) -
Prevalence and chemotherapy-induced reactivation of occult hepatitis B virus among hepatitis B surface antigen negative patients with diffuse large B-cell lymphoma: Significance of hepatitis B core antibodies screening
by: Tamer A. Elbedewy, et al.
Published: (2015-03-01)